Fam-trastuzumab deruxtecan User Reviews & Ratings (Page 2)
Brand names: Enhertu
Fam-trastuzumab deruxtecan has an average rating of 7.9 out of 10 from a total of 34 reviews on Drugs.com. 71% of reviewers reported a positive experience, while 6% reported a negative experience.
Reviews for Fam-trastuzumab deruxtecan
- Pus...
- Taken for less than 1 month
- May 27, 2023
For Breast Cancer, Metastatic "I experienced stomach pain and fatigue during the first week. After week three, my hair started to thin, and my blood count is very low."
- Eli...
- Taken for 6 months to 1 year
- January 13, 2024
For Breast Cancer, Metastatic "I am coping okay, but there are times when symptoms are pretty bad. Fatigue and appetite are not so good. Hair thinning."
Frequently asked questions
- What is the success rate of Enhertu in metastatic breast cancer?
- Is Enhertu a chemotherapy drug? What's Enhertu used for?
- bem...
- Taken for 1 to 6 months
- June 22, 2023
For Breast Cancer, Metastatic "Side effects became worse after each treatment, and the side effects lasted for a long time."
- Liz...
- December 21, 2023
For Breast Cancer "It is saving my life & has limited side effects. While I am on it, my tumor did not spread or grow."
Are you taking this medicine?
Your review helps others make informed decisions.- ALP...
- Taken for 1 to 6 months
- October 18, 2024
For Breast Cancer "So far, things have been going well, very few side effects, and my cancer seems to be under control."
- Jan...
- Taken for 1 to 6 months
- March 19, 2024
For Breast Cancer "Only 2 infusions, on Zofran and dexamethasone, caused severe constipation and cramps. Tumor markers next, only 2 infusions."
- KUM...
- Taken for 1 to 2 years
- March 30, 2024
For Breast Cancer "True and Best Injection for HER2-POSITIVE Treatment."
- Ano...
- Taken for 2 to 5 years
- May 19, 2025
"Common side effects I experienced: - dry mouth - dry skin - muscle and joint aches - nausea - bloating - hyperacidity"
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Arimidex
Arimidex is used to treat breast cancer in postmenopausal women. Learn about side effects ...
Femara
Femara lowers estrogen levels and is used to treat breast cancer in postmenopausal women. Learn ...
Are you taking this medicine?
Your review helps others make informed decisions.More about fam-trastuzumab deruxtecan
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: HER2 inhibitors
- En español
For Breast Cancer, Metastatic "Primary persistent side effects are dry mouth, change in taste, fatigue, some nausea. Hair loss but some regrowing even during treatment. Mixed results on effectiveness."